Bulk Rituximab Monoclonal Antibody from China
Rituximab targets CD20 on B-cells for lymphoma and autoimmune treatment, a biotech-produced antibody. As an unmixed product not for retail, it fits HTS 3002.13.00 immunological products definition.
Duty Rate — China → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Ensure BLA (Biologics License Application) reference; provide glycosylation profile analysis; declare bulk quantity to affirm non-retail status